Eliav Barr, Merck Research Laboratories CMO
October 12, 2022 10:59 AM EDT
Deals
R&D

Mer­ck pays Mod­er­na $250M to con­tin­ue Keytru­da, can­cer vac­cine com­bo stud­ies

Max Gelman

Senior Editor

Af­ter near­ly six years of work­ing to­geth­er, Mer­ck and Mod­er­na are tak­ing the next step in their can­cer vac­cine part­ner­ship.

Mer­ck is opt­ing in­to a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times